» Articles » PMID: 39942791

Microbial Trojan Horses: Virulence Factors As Key Players in Neurodegenerative Diseases

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2025 Feb 13
PMID 39942791
Authors
Affiliations
Soon will be listed here.
Abstract

Changes in population demographics indicate that the elderly population will reach 2.1 billion worldwide by 2050. In parallel, there will be an increase in neurodegenerative diseases such as Alzheimer's and Parkinson's. This review explores dysbiosis occurring in these pathologies and how virulence factors contribute to the worsening or development of clinical conditions, and it summarizes existing and potential ways to combat microorganisms related to these diseases. Microbiota imbalances can contribute to the progression of neurodegenerative diseases by increasing intestinal permeability, exchanging information through innervation, and even acting as a Trojan horse affecting immune cells. The microorganisms of the microbiota produce virulence factors to protect themselves from host defenses, many of which contribute to neurodegenerative diseases. These virulence factors are expressed according to the genetic composition of each microorganism, leading to a wide range of factors to be considered. Among the main virulence factors are LPS, urease, curli proteins, amyloidogenic proteins, VacA, and CagA. These factors can also be packed into bacterial outer membrane vesicles, which transport proteins, RNA, and DNA, enabling distal communication that impacts various diseases, including Alzheimer's and Parkinson's.

References
1.
Weberpals M, Hermes M, Hermann S, Kummer M, Terwel D, Semmler A . NOS2 gene deficiency protects from sepsis-induced long-term cognitive deficits. J Neurosci. 2009; 29(45):14177-84. PMC: 6665081. DOI: 10.1523/JNEUROSCI.3238-09.2009. View

2.
Christensen L, Jensen K, Nielsen J, Vad B, Christiansen G, Otzen D . Reducing the Amyloidogenicity of Functional Amyloid Protein FapC Increases Its Ability To Inhibit α-Synuclein Fibrillation. ACS Omega. 2019; 4(2):4029-4039. PMC: 6647998. DOI: 10.1021/acsomega.8b03590. View

3.
Gonzalez M, Diaz P, Sandoval-Borquez A, Herrera D, Quest A . Outer Membrane Vesicles and Extracellular Vesicles from -Infected Cells in Gastric Disease Development. Int J Mol Sci. 2021; 22(9). PMC: 8124820. DOI: 10.3390/ijms22094823. View

4.
Maeshima N, Fernandez R . Recognition of lipid A variants by the TLR4-MD-2 receptor complex. Front Cell Infect Microbiol. 2013; 3:3. PMC: 3569842. DOI: 10.3389/fcimb.2013.00003. View

5.
Philipson O, Lord A, Gumucio A, OCallaghan P, Lannfelt L, Nilsson L . Animal models of amyloid-beta-related pathologies in Alzheimer's disease. FEBS J. 2010; 277(6):1389-409. DOI: 10.1111/j.1742-4658.2010.07564.x. View